top of page

Introducing CLL Immunisation Centre

Vaccination Journey

The Journey of the Little Vial

Edward Jenner.jpg

Who was Edward Jenner?

The Father of Immunology

Edward Jenner (May 17, 1749 - January 26, 1823) was an English surgeon and discoverer of vaccination for smallpox, a feared disease caused by the variola virus with a mortality rate of up to 30%. Jenner had noticed that people who had been infected with cowpox which, we now know bears a strong resemblance to the smallpox virus, never developed the latter. Thus, in May 1796 Jenner found a young dairymaid, Sarah Nelmes, who had fresh cowpox lesions on her hand. Using matter from Sarah’s lesions, he inoculated an eight-year-old boy, James Phipps, who had never had smallpox. Three months later, Jenner inoculated the boy again, this time with smallpox matter. Amazingly, James was completely protected from the deadly disease. Due to Jenner’s revolutionary discovery, smallpox deaths plunged; following in his legacy, global vaccine programs were able to completely eradicate the virus in 1977. 33rd World Health Assembly declared the world free of smallpox disease on May 8, 1980. Many people consider smallpox eradication to be the biggest achievement in international public health.

SINOVAC COVID-19 Vaccine

Sinovac.png

Sinovac CoronaVac® is innovated and manufactured by SINOVAC, a pharmaceutical company based in Beijing. On 1 June 2021, the World Health Organization (WHO) approved this vaccine for emergency use. As of January 2022, about 60 countries have authorized the vaccine for emergency use or marketing use with conditions, 6 of which have cleared it for children. 

​

SINOVAC COVID-19 vaccine is the most widely used COVID-19 vaccine around the world and it is one of the least likely COVID-19 vaccines to cause side effects after the injection.

 

As of 29 January 2022, 2.7 billion doses of SINOVAC COVID-19 vaccine have been supplied to 60 countries of which 2.3 billion doses have been administered.

​

In Myanmar, the SINOVAC COVID-19 vaccine has been in use since 8 August 2021 and those aged 12 and above are qualified to receive the Sinovac COVID-19 vaccine.

Vaccine preventable diseases.jpg
bottom of page